Oxford Lasers has announced that it will be able to supply its EnVision spray characterization system in Europe following a decision in its favor by the European Patent Office Board of Appeal. The decision revoked European patent 1210580, based on US patent 6,785,400, “Spray Data Acquisition Method,” which belongs to Proveris Scientifc.
Oxford Lasers Imaging Head Seamus Murphy commented, “We are delighted with the outcome of this case. It removes an entirely unfounded barrier to open competition in Europe. We look forward to supplying our advanced Envision system to pharmaceutical companies who wish to characterize sprays for inhaled drug delivery devices.”
Read the Oxford Lasers press release.
